BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20624522)

  • 1. Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells.
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Hiraoka N; Oka S; Miyoshi T; Takubo T; Tsuji M; Hanafusa T
    Hum Pathol; 2010 Aug; 41(8):1196-9. PubMed ID: 20624522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome.
    Nakayama-Ichiyama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Hiraoka N; Takayama A; Iwaki K; Oka S; Takubo T; Tsuji M; Hanafusa T
    Leuk Res; 2010 Jul; 34(7):e157-9. PubMed ID: 20167371
    [No Abstract]   [Full Text] [Related]  

  • 3. Paediatric Hodgkin lymphoma with Reed-Sternberg and mononuclear Hodgkin cells in the bone marrow aspirate.
    Swart L; Shuttleworth MH; Opie JJ; van Schalkwyk WA
    Br J Haematol; 2012 Apr; 157(1):2. PubMed ID: 22329501
    [No Abstract]   [Full Text] [Related]  

  • 4. Hodgkin lymphoma with cutaneous involvement.
    Hsia CC; Howson-Jan K; Rizkalla KS
    Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
    Greaves WO; Bueso-Ramos C; Fayad L
    J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma.
    Dinand V; Malik A; Unni R; Arya LS; Pandey RM; Dawar R
    Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
    Kobayashi K; Yokote T; Akioka T; Hara S; Oka S; Hiraoka N; Hirata Y; Miyoshi T; Tsuji M; Hanafusa T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1327-30. PubMed ID: 17687225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
    Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
    Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin s disease with nephrotic syndrome as a complication of ulcerative colitis: case report.
    Basić-Jukić N; Radman I; Roncević T; Jakić-Razumović J
    Croat Med J; 2002 Oct; 43(5):573-5. PubMed ID: 12402399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma].
    Takashima H; Kawashima K; Isayama Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1172-4. PubMed ID: 14978934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relapse of Hodgkin disease after 17 years of complete remission. A case report].
    Osorio G; Caglevic C
    Rev Med Chil; 2003 Feb; 131(2):197-9. PubMed ID: 12708259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
    Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA
    Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous granulomas as the first manifestation of Hodgkin's disease.
    Macaya A; Servitje O; Moreno A; Peyrí J
    Eur J Dermatol; 2003; 13(3):299-301. PubMed ID: 12804995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Marginal zone lymphoma associated with Reed-Sternberg cells: A challenge for the pathologist].
    Leus HJ; Robin V; Molina TJ; Forsyth R; Dehou MF
    Ann Pathol; 2021 Apr; 41(2):212-215. PubMed ID: 32798091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.
    Mestre F; Gutiérrez A; Rodriguez J; Ramos R; Garcia JF; Martinez-Serra J; Casasus M; Nicolau C; Bento L; Herraez I; Lopez-Perezagua P; Daumal J; Besalduch J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):84-90. PubMed ID: 25475251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.